Transcriptome-inferred CIN-like fields mark antigen-presentation-low, immune-cold spatial neighborhoods
Abstract
Cancer immune escape is usually interpreted as either a tumor-cell-intrinsic antigen-presentation defect or an immune-cold microenvironment. How these states are spatially arranged relative to chromosomal-instability-like genotype states remains unresolved. Here, spatial transcriptomic, single-cell and clinical transcriptomic analyses show that transcriptome-inferred CIN-like fields mark antigen-presentation-low, immune-cold neighborhoods. Across 14 melanoma tissue sections, the interaction between inferred copy-number-like burden and chromosome-expression deviation was associated with reduced MHC-I antigen-presentation activity after adjustment for tumor state, immune inflammation, technical covariates and spatial coordinates. CIN-high/AP-low spots formed coherent neighborhoods enriched for AP-low neighbors but depleted of immune-high and IFN-high neighbors under block-preserving spatial nulls. Two breast cancer Visium sections reproduced AP-low neighborhood topology, while malignant melanoma single-cell RNA-seq supported a tumor-intrinsic CNA-by-chromosome-deviation association with AP repression. Patient-level TCGA analyses linked the adverse genotype-ecotype score to poor melanoma survival. These results define transcriptome-inferred CIN-like fields as spatial correlates of immune-cold antigen-presentation failure.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Specific Aneuploidies Predict Immune Evasion and Poor Immunotherapy Response in Melanoma
Lizabeth Katsnelson, Shini Chen, … Teresa Davoli·bioRxiv·Apr 15, 2026
- Tumor MHCII immunity requires in situ antigen presentation by cancer-associated fibroblasts.
D. Kerdidani, E. Aerakis, … M. Tsoumakidou·bioRxiv·Mar 24, 2020
- Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma
A. Fernandez, W. Deng, … D. J. Klinke·The EMBO ReportsPeer-reviewed·Jan 31, 2022
- Head-to-head comparison of CCN4, DNMT3A, PTPN11, and SPARC as suppressors of anti-tumor immunity
A. C. Pirkey, W. Deng, … D. J. Klinke·bioRxiv·Apr 1, 2022
- Spatial polarization of endothelial ICAM-1 governs T-cell exclusion in melanoma
Ha-Ram Park, S. C. Kim, … Minah Kim·bioRxiv·Mar 23, 2026
- Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma
R. C. Augustin, S. Newman, … R. Bao·bioRxiv·Aug 24, 2023